These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37529763)

  • 1. Funding and financial sustainability of pharmacovigilance: suggested models for funding pharmacovigilance in resource-limited African countries.
    Isah AO; Opadeyi AO; Tumwijukye H; Cobelens F; Smith D; Ndomondo-Sigonda M; Harmark L; Tanui P; Tiemersma E; Mmbaga BT; Mahlangu G; Ayinbuomwan SA; Soulaymani R; Pandit JM
    Ther Adv Drug Saf; 2023; 14():20420986231188836. PubMed ID: 37529763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National medicines regulatory authorities financial sustainability in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
    PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacovigilance in India, Uganda and South Africa with reference to WHO's minimum requirements.
    Maigetter K; Pollock AM; Kadam A; Ward K; Weiss MG
    Int J Health Policy Manag; 2015 Mar; 4(5):295-305. PubMed ID: 25905480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.
    Kovacs SD; Mills BM; Stergachis A
    Malar J; 2017 Jul; 16(1):282. PubMed ID: 28693488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences.
    Ampadu HH; Hoekman J; Arhinful D; Amoama-Dapaah M; Leufkens HGM; Dodoo ANO
    Global Health; 2018 Nov; 14(1):109. PubMed ID: 30445979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.
    Olsson S; Pal SN; Stergachis A; Couper M
    Drug Saf; 2010 Aug; 33(8):689-703. PubMed ID: 20635827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific features of medicines safety and pharmacovigilance in Africa.
    Isah AO; Pal SN; Olsson S; Dodoo A; Bencheikh RS
    Ther Adv Drug Saf; 2012 Feb; 3(1):25-34. PubMed ID: 25083223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Current State of Pharmacovigilance System in Pakistan Using Indicator-Based Assessment Tool.
    Khan MAA; Hamid S; Ur-Rehman T; Babar ZU
    Front Pharmacol; 2021; 12():789103. PubMed ID: 35095498
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug safety in Africa: a review of systems and resources for pharmacovigilance.
    Ndagije HB; Walusimbi D; Atuhaire J; Ampaire S
    Expert Opin Drug Saf; 2023; 22(10):891-895. PubMed ID: 37676033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining health facility financing in Kenya in the context of devolution.
    Kairu A; Orangi S; Mbuthia B; Ondera J; Ravishankar N; Barasa E
    BMC Health Serv Res; 2021 Oct; 21(1):1086. PubMed ID: 34645443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone.
    Abiri OT; Johnson WCN
    J Pharm Policy Pract; 2019; 12():13. PubMed ID: 31198563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health financing policies during the COVID-19 pandemic and implications for universal health care: a case study of 15 countries.
    De Foo C; Verma M; Tan SY; Hamer J; van der Mark N; Pholpark A; Hanvoravongchai P; Cheh PLJ; Marthias T; Mahendradhata Y; Putri LP; Hafidz F; Giang KB; Khuc THH; Van Minh H; Wu S; Caamal-Olvera CG; Orive G; Wang H; Nachuk S; Lim J; de Oliveira Cruz V; Yates R; Legido-Quigley H
    Lancet Glob Health; 2023 Dec; 11(12):e1964-e1977. PubMed ID: 37973344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fall and rise of cost sharing in Kenya: the impact of phased implementation.
    Collins D; Quick JD; Musau SN; Kraushaar K; Hussein IM
    Health Policy Plan; 1996 Mar; 11(1):52-63. PubMed ID: 10155878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective Pharmacovigilance System Development: EFPIA-IPVG Consensus Recommendations.
    Peters T; Soanes N; Abbas M; Ahmad J; Delumeau JC; Herrero-Martinez E; Paramananda M; Piper J; Smail-Aoudia F; van der Spuij W; Veizovic T; Winstanley G;
    Drug Saf; 2021 Jan; 44(1):17-28. PubMed ID: 33289904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grant recipients' rights in question.
    Willson PD
    Plan Parent Rev; 1984; 4(1):13-4. PubMed ID: 12266274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo.
    Nzolo D; Kuemmerle A; Lula Y; Ntamabyaliro N; Engo A; Mvete B; Liwono J; Lusakibanza M; Mesia G; Burri C; Mampunza S; Tona G
    Ther Adv Drug Saf; 2019; 10():2042098619864853. PubMed ID: 31360433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stakeholders' Perspectives on the Financial Sustainability of the HIV Response in Nigeria: A Qualitative Study.
    Ogbuabor D; Olwande C; Semini I; Onwujekwe O; Olaifa Y; Ukanwa C
    Glob Health Sci Pract; 2023 Apr; 11(2):. PubMed ID: 37116920
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.